Human Gene LINC00461 (uc003kjg.3) Description and Page Index
  Description: Homo sapiens long intergenic non-protein coding RNA 461 (LINC00461), transcript variant 1, non-coding RNA.
RefSeq Summary (NR_024384): This is an evolutionarily conserved gene that produces alternatively spliced long non-coding RNAs that may be expressed predominantly in the brain and visual cortex. These transcripts may be involved in tumorigenesis, as depletion by siRNA suppressed glioma cell division. Transcripts may also bind to and regulate the activity of miR-411-5p and argonaut 2, thereby altering the expression of genes involved in tumor growth. [provided by RefSeq, Nov 2017].
Transcript (Including UTRs)
   Position: hg19 chr5:87,960,263-87,972,116 Size: 11,854 Total Exon Count: 4 Strand: -


Page IndexSequence and LinksRNA-Seq ExpressionMicroarray ExpressionOther SpeciesmRNA Descriptions
Other NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr5:87,960,263-87,972,116)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
BioGPSCGAPEnsemblExonPrimerH-INVHGNC
LynxPubMedStanford SOURCE

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 8.38 RPKM in Brain - Nucleus accumbens (basal ganglia)
Total median expression: 85.39 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  BC047100 - Homo sapiens cDNA clone IMAGE:5287322.
BC048008 - Homo sapiens hypothetical LOC645323, mRNA (cDNA clone IMAGE:5295779).
MA013417 - WO 2018003988-A/37: Nucleic Acids and Composition for Treating Tumors Including Brain Tumor.
BC036480 - Homo sapiens cDNA clone IMAGE:5260726.
MA013418 - WO 2018003988-A/38: Nucleic Acids and Composition for Treating Tumors Including Brain Tumor.
AK055372 - Homo sapiens cDNA FLJ30810 fis, clone FEBRA2001440.
MA013411 - WO 2018003988-A/31: Nucleic Acids and Composition for Treating Tumors Including Brain Tumor.
AK091356 - Homo sapiens cDNA FLJ34037 fis, clone FCBBF2005439.
AX746931 - Sequence 456 from Patent EP1308459.
MA013406 - WO 2018003988-A/26: Nucleic Acids and Composition for Treating Tumors Including Brain Tumor.
MA013410 - WO 2018003988-A/30: Nucleic Acids and Composition for Treating Tumors Including Brain Tumor.
AK311230 - Homo sapiens cDNA, FLJ18272.
CS266326 - Sequence 18 from Patent WO2005118806.
DL076488 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004138 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM119567 - Targeting Cells With Altered miRNA Expression.
FU261058 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763560 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525888 - Nucleic acid controling mast cell degranulation.
FW421480 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HH826053 - Sequence 6 from Patent WO2010100328.
HV304459 - JP 2009531018-A/26: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304957 - JP 2009531019-A/26: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119166 - JP 2013046612-A/26: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367351 - JP 2012228254-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411744 - JP 2014000079-A/18: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505120 - JP 2014502606-A/22: MELANOMA TREATMENTS.
HW505147 - JP 2014502606-A/49: MELANOMA TREATMENTS.
HW589495 - JP 2013121348-A/26: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674090 - JP 2014217381-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067032 - JP 2014012020-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408189 - JP 2015528002-A/786: CHIRAL CONTROL.
HZ413299 - JP 2014060993-A/26: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427456 - JP 2014217384-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428259 - JP 2014217385-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429062 - JP 2014217386-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429865 - JP 2014217387-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501510 - JP 2016025853-A/26: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769122 - JP 2014223080-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058516 - Sequence 18 from Patent EP2298893.
JA059319 - Sequence 18 from Patent EP2298894.
JA073642 - Sequence 18 from Patent EP2281887.
JA104779 - Sequence 18 from Patent EP2302051.
JA106119 - Sequence 18 from Patent EP2302052.
JA106922 - Sequence 18 from Patent EP2302053.
JA107725 - Sequence 18 from Patent EP2302054.
JA108528 - Sequence 18 from Patent EP2302055.
JA109331 - Sequence 18 from Patent EP2302056.
JA191847 - Sequence 18 from Patent EP2290066.
JA192746 - Sequence 18 from Patent EP2290067.
JA193645 - Sequence 18 from Patent EP2290068.
JA194544 - Sequence 18 from Patent EP2290069.
JA195443 - Sequence 18 from Patent EP2290070.
JA196342 - Sequence 18 from Patent EP2290071.
JA197241 - Sequence 18 from Patent EP2290072.
JA198140 - Sequence 18 from Patent EP2290073.
JA199039 - Sequence 18 from Patent EP2290074.
JA199938 - Sequence 18 from Patent EP2290075.
JA200837 - Sequence 18 from Patent EP2290076.
JA217959 - Sequence 18 from Patent EP2281888.
JA226110 - Sequence 18 from Patent EP2292755.
JA228965 - Sequence 18 from Patent EP2292756.
JA257236 - Sequence 18 from Patent EP2284265.
JA278516 - Sequence 18 from Patent EP2281886.
JA284402 - Sequence 18 from Patent EP2281889.
JA292455 - Sequence 18 from Patent EP2287303.
JA317641 - Sequence 18 from Patent EP2314688.
JA374700 - Sequence 18 from Patent EP2322616.
JA525876 - Sequence 26 from Patent EP2369011.
JA526383 - Sequence 26 from Patent EP2369012.
JA526890 - Sequence 26 from Patent EP2369013.
JA535819 - Sequence 26 from Patent EP2371971.
JA787824 - Sequence 26 from Patent EP2479285.
JA788322 - Sequence 26 from Patent EP2479286.
JA810656 - Sequence 26 from Patent EP2468890.
JA811154 - Sequence 26 from Patent EP2468891.
JA811652 - Sequence 26 from Patent EP2468893.
JA812150 - Sequence 26 from Patent EP2468894.
JA812648 - Sequence 26 from Patent EP2468895.
JA813146 - Sequence 26 from Patent EP2468896.
JA813644 - Sequence 26 from Patent EP2468897.
JA814142 - Sequence 26 from Patent EP2468898.
JA814640 - Sequence 26 from Patent EP2468899.
JA816883 - Sequence 26 from Patent EP2468892.
JA825695 - Sequence 26 from Patent EP2471956.
JA826193 - Sequence 26 from Patent EP2471958.
JB024480 - Sequence 26 from Patent EP2505668.
JB024978 - Sequence 26 from Patent EP2505669.
JB079365 - Sequence 26 from Patent EP2487252.
JB079863 - Sequence 26 from Patent EP2487253.
JB080361 - Sequence 26 from Patent EP2487254.
JB080859 - Sequence 26 from Patent EP2487255.
JB081357 - Sequence 26 from Patent EP2487256.
JB081855 - Sequence 26 from Patent EP2487257.
JB082353 - Sequence 26 from Patent EP2487258.
JB082851 - Sequence 26 from Patent EP2487259.
JB083349 - Sequence 26 from Patent EP2487260.
JB083847 - Sequence 26 from Patent EP2487261.
JB084345 - Sequence 26 from Patent EP2487262.
JB084843 - Sequence 26 from Patent EP2487263.
JB087521 - Sequence 26 from Patent EP2502630.
JB147725 - Sequence 26 from Patent EP2484782.
JB148223 - Sequence 26 from Patent EP2484783.
JB152948 - Sequence 26 from Patent EP2514433.
JB153446 - Sequence 26 from Patent EP2514434.
JB622035 - Sequence 26 from Patent EP2586454.
JB622533 - Sequence 26 from Patent EP2586455.
JC001596 - Sequence 26 from Patent EP2591794.
JC037612 - Sequence 140 from Patent EP2643479.
JC221543 - Sequence 18 from Patent EP2471923.
JC268109 - Sequence 18 from Patent EP2471924.
JC340417 - Sequence 18 from Patent EP2471922.
JC469663 - Sequence 18 from Patent EP2471921.
JC990452 - Sequence 18 from Patent EP2808390.
LF714555 - JP 2016165292-A/18: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856489 - JP 2015142597-A/18: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051523 - KR 1020150036642-A/789: CHIRAL CONTROL.
LQ224799 - Sequence 6 from Patent WO2016030899.
LQ270773 - Sequence 101 from Patent WO2016071350.
AK308694 - Homo sapiens cDNA, FLJ98735.
CS266516 - Sequence 208 from Patent WO2005118806.
DL076678 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004328 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261171 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763673 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW421670 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304572 - JP 2009531018-A/139: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305070 - JP 2009531019-A/139: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119279 - JP 2013046612-A/139: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367541 - JP 2012228254-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411934 - JP 2014000079-A/208: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589608 - JP 2013121348-A/139: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674280 - JP 2014217381-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067222 - JP 2014012020-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ413412 - JP 2014060993-A/139: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427646 - JP 2014217384-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428449 - JP 2014217385-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429252 - JP 2014217386-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430055 - JP 2014217387-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501623 - JP 2016025853-A/139: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769312 - JP 2014223080-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058706 - Sequence 208 from Patent EP2298893.
JA059509 - Sequence 208 from Patent EP2298894.
JA073832 - Sequence 208 from Patent EP2281887.
JA104969 - Sequence 208 from Patent EP2302051.
JA106309 - Sequence 208 from Patent EP2302052.
JA107112 - Sequence 208 from Patent EP2302053.
JA107915 - Sequence 208 from Patent EP2302054.
JA108718 - Sequence 208 from Patent EP2302055.
JA109521 - Sequence 208 from Patent EP2302056.
JA192037 - Sequence 208 from Patent EP2290066.
JA192936 - Sequence 208 from Patent EP2290067.
JA193835 - Sequence 208 from Patent EP2290068.
JA194734 - Sequence 208 from Patent EP2290069.
JA195633 - Sequence 208 from Patent EP2290070.
JA196532 - Sequence 208 from Patent EP2290071.
JA197431 - Sequence 208 from Patent EP2290072.
JA198330 - Sequence 208 from Patent EP2290073.
JA199229 - Sequence 208 from Patent EP2290074.
JA200128 - Sequence 208 from Patent EP2290075.
JA201027 - Sequence 208 from Patent EP2290076.
JA218149 - Sequence 208 from Patent EP2281888.
JA226300 - Sequence 208 from Patent EP2292755.
JA229155 - Sequence 208 from Patent EP2292756.
JA257426 - Sequence 208 from Patent EP2284265.
JA278706 - Sequence 208 from Patent EP2281886.
JA284592 - Sequence 208 from Patent EP2281889.
JA292645 - Sequence 208 from Patent EP2287303.
JA317831 - Sequence 208 from Patent EP2314688.
JA374890 - Sequence 208 from Patent EP2322616.
JA525989 - Sequence 139 from Patent EP2369011.
JA526496 - Sequence 139 from Patent EP2369012.
JA527003 - Sequence 139 from Patent EP2369013.
JA535932 - Sequence 139 from Patent EP2371971.
JA787937 - Sequence 139 from Patent EP2479285.
JA788435 - Sequence 139 from Patent EP2479286.
JA810769 - Sequence 139 from Patent EP2468890.
JA811267 - Sequence 139 from Patent EP2468891.
JA811765 - Sequence 139 from Patent EP2468893.
JA812263 - Sequence 139 from Patent EP2468894.
JA812761 - Sequence 139 from Patent EP2468895.
JA813259 - Sequence 139 from Patent EP2468896.
JA813757 - Sequence 139 from Patent EP2468897.
JA814255 - Sequence 139 from Patent EP2468898.
JA814753 - Sequence 139 from Patent EP2468899.
JA816996 - Sequence 139 from Patent EP2468892.
JA825808 - Sequence 139 from Patent EP2471956.
JA826306 - Sequence 139 from Patent EP2471958.
JB024593 - Sequence 139 from Patent EP2505668.
JB025091 - Sequence 139 from Patent EP2505669.
JB079478 - Sequence 139 from Patent EP2487252.
JB079976 - Sequence 139 from Patent EP2487253.
JB080474 - Sequence 139 from Patent EP2487254.
JB080972 - Sequence 139 from Patent EP2487255.
JB081470 - Sequence 139 from Patent EP2487256.
JB081968 - Sequence 139 from Patent EP2487257.
JB082466 - Sequence 139 from Patent EP2487258.
JB082964 - Sequence 139 from Patent EP2487259.
JB083462 - Sequence 139 from Patent EP2487260.
JB083960 - Sequence 139 from Patent EP2487261.
JB084458 - Sequence 139 from Patent EP2487262.
JB084956 - Sequence 139 from Patent EP2487263.
JB087634 - Sequence 139 from Patent EP2502630.
JB147838 - Sequence 139 from Patent EP2484782.
JB148336 - Sequence 139 from Patent EP2484783.
JB153061 - Sequence 139 from Patent EP2514433.
JB153559 - Sequence 139 from Patent EP2514434.
JB622148 - Sequence 139 from Patent EP2586454.
JB622646 - Sequence 139 from Patent EP2586455.
JC001709 - Sequence 139 from Patent EP2591794.
JC221733 - Sequence 208 from Patent EP2471923.
JC268299 - Sequence 208 from Patent EP2471924.
JC340607 - Sequence 208 from Patent EP2471922.
JC469853 - Sequence 208 from Patent EP2471921.
JC990642 - Sequence 208 from Patent EP2808390.
LF714745 - JP 2016165292-A/208: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856679 - JP 2015142597-A/208: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
CS548544 - Sequence 1574 from Patent EP1777301.
FU261353 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763855 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW312440 - DETECTING NUCLEIC ACIDS.
FZ421156 - JP 2010539978-A/56: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
HV304754 - JP 2009531018-A/321: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305252 - JP 2009531019-A/321: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV954016 - JP 2012518421-A/928: METHODS OF DETECTING LUNG CANCER.
HW119461 - JP 2013046612-A/321: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW502470 - JP 2014050389-A/56: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF.
HW589790 - JP 2013121348-A/321: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413594 - JP 2014060993-A/321: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501805 - JP 2016025853-A/321: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526171 - Sequence 321 from Patent EP2369011.
JA526678 - Sequence 321 from Patent EP2369012.
JA527185 - Sequence 321 from Patent EP2369013.
JA536114 - Sequence 321 from Patent EP2371971.
JA715146 - Sequence 928 from Patent EP2401406.
JA788119 - Sequence 321 from Patent EP2479285.
JA788617 - Sequence 321 from Patent EP2479286.
JA810951 - Sequence 321 from Patent EP2468890.
JA811449 - Sequence 321 from Patent EP2468891.
JA811947 - Sequence 321 from Patent EP2468893.
JA812445 - Sequence 321 from Patent EP2468894.
JA812943 - Sequence 321 from Patent EP2468895.
JA813441 - Sequence 321 from Patent EP2468896.
JA813939 - Sequence 321 from Patent EP2468897.
JA814437 - Sequence 321 from Patent EP2468898.
JA814935 - Sequence 321 from Patent EP2468899.
JA817178 - Sequence 321 from Patent EP2468892.
JA825990 - Sequence 321 from Patent EP2471956.
JA826488 - Sequence 321 from Patent EP2471958.
JB024775 - Sequence 321 from Patent EP2505668.
JB025273 - Sequence 321 from Patent EP2505669.
JB079660 - Sequence 321 from Patent EP2487252.
JB080158 - Sequence 321 from Patent EP2487253.
JB080656 - Sequence 321 from Patent EP2487254.
JB081154 - Sequence 321 from Patent EP2487255.
JB081652 - Sequence 321 from Patent EP2487256.
JB082150 - Sequence 321 from Patent EP2487257.
JB082648 - Sequence 321 from Patent EP2487258.
JB083146 - Sequence 321 from Patent EP2487259.
JB083644 - Sequence 321 from Patent EP2487260.
JB084142 - Sequence 321 from Patent EP2487261.
JB084640 - Sequence 321 from Patent EP2487262.
JB085138 - Sequence 321 from Patent EP2487263.
JB087816 - Sequence 321 from Patent EP2502630.
JB148020 - Sequence 321 from Patent EP2484782.
JB148518 - Sequence 321 from Patent EP2484783.
JB153243 - Sequence 321 from Patent EP2514433.
JB153741 - Sequence 321 from Patent EP2514434.
JB622330 - Sequence 321 from Patent EP2586454.
JB622828 - Sequence 321 from Patent EP2586455.
JC001891 - Sequence 321 from Patent EP2591794.
JC334282 - Sequence 200 from Patent EP2487240.
FW364628 - Oligonucleotides for modulating target RNA activity.
HI560807 - Sequence 22 from Patent EP2190992.
HI648421 - Sequence 2 from Patent WO2010122109.
HI964747 - Sequence 32 from Patent WO2010139812.
HI966027 - Sequence 347 from Patent WO2010139811.
HI966893 - Sequence 347 from Patent WO2010139810.
HV593853 - JP 2010538610-A/66: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV593908 - JP 2010538653-A/22: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595538 - JP 2010539959-A/919: Micromirs.
HW048308 - JP 2012524758-A/2: METHOD FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA.
HW062433 - JP 2012530054-A/3: METHODS, SYSTEMS, AND COMPOSITIONS FOR NEURONAL DIFFERENTIATION OF MULTIPOTENT STROMAL CELLS.
HW122103 - JP 2013503620-A/25: Identifying viral cell tropism.
HW155319 - JP 2013509169-A/5: Circulating miRNAs as non-invasive markers for diagnosis and staging in prostate cancer.
HW505488 - JP 2014502606-A/390: MELANOMA TREATMENTS.
HW505489 - JP 2014502606-A/391: MELANOMA TREATMENTS.
HW505490 - JP 2014502606-A/392: MELANOMA TREATMENTS.
HW505508 - JP 2014502606-A/410: MELANOMA TREATMENTS.
HW505509 - JP 2014502606-A/411: MELANOMA TREATMENTS.
HW505510 - JP 2014502606-A/412: MELANOMA TREATMENTS.
HW913489 - JP 2015504307-A/249: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ082826 - JP 2015513906-A/183: Stem Cell Microparticles.
HZ158095 - JP 2015130862-A/919: Micromirs.
HZ186941 - JP 2015146814-A/690: Oligonucleotides for modulating target RNA activity.
HZ436607 - JP 2015529450-A/183: Stem Cell Microparticles.
HZ482639 - JP 2015535430-A/3145: TERMINALLY MODIFIED RNA.
HZ792570 - JP 2016504050-A/4315: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA325390 - Sequence 5 from Patent EP2316972.
JA390837 - Sequence 5 from Patent WO2011051471.
JA400785 - Sequence 32 from Patent WO2011080318.
JA401763 - Sequence 32 from Patent WO2011080315.
JA402770 - Sequence 32 from Patent WO2011080316.
JA405401 - Sequence 32 from Patent EP2336353.
JA427270 - Sequence 603 from Patent WO2011072177.
JA428927 - Sequence 32 from Patent WO2011095623.
JA757911 - Sequence 44 from Patent WO2012010584.
JA791818 - Sequence 220 from Patent WO2012089772.
JB022324 - Sequence 166 from Patent WO2013026685.
JB022878 - Sequence 132 from Patent WO2013026684.
JB359247 - Sequence 3 from Patent EP2440660.
JB616172 - Sequence 2 from Patent WO2013107459.
JB620287 - Sequence 267 from Patent WO2013063544.
JB624202 - Sequence 22 from Patent EP2610342.
JB778870 - Sequence 249 from Patent WO2013078283.
JC037538 - Sequence 66 from Patent EP2643479.
JC171811 - Sequence 183 from Patent WO2013150303.
JC244395 - Sequence 15 from Patent WO2012020308.
JC515302 - Sequence 5555 from Patent WO2014113089.
JC572622 - Sequence 183 from Patent WO2014125276.
JC582310 - Sequence 183 from Patent WO2014125277.
JE954006 - Sequence 183 from Patent WO2015052526.
JE955759 - Sequence 183 from Patent WO2015052527.
LF137511 - JP 2016507550-A/183: Method of Producing Microparticles.
LF160634 - JP 2016513950-A/700: Oligomers with improved off-target profile.
LF162476 - JP 2016513095-A/183: Stem Cell Microparticles and miRNA.
LF636392 - JP 2016519076-A/166: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF857617 - JP 2015130879-A/66: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LF953228 - JP 2016534103-A/183: Stem Cell Microparticles and miRNA.
LG005573 - KR 1020150004822-A/183: STEM CELL MICROPARTICLES.
LG053269 - KR 1020150059168-A/183: STEM CELL MICROPARTICLES.
LG134549 - KR 1020150131312-A/167: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240508 - KR 1020160035087-A/183: STEM CELL MICROPARTICLES AND MIRNA.
LP643862 - Sequence 20 from Patent WO2015091892.
LP726653 - Sequence 347 from Patent EP2883966.
LP818923 - Sequence 347 from Patent EP3296406.
LP938865 - Sequence 347 from Patent EP3184651.
LQ072890 - Sequence 3214 from Patent EP2964234.
LQ278636 - Sequence 175 from Patent WO2016066288.
LQ500652 - Sequence 66 from Patent EP3048177.
LQ754459 - Sequence 37 from Patent EP3329005.
LV470593 - JP 2016534036-A/183: Stem Cell Microparticles and miRNA.
LY405603 - KR 1020160117535-A/908: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504711 - KR 1020170035932-A/100: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ234298 - JP 2017184756-A/690: Oligonucleotides for modulating target RNA activity.
LZ242992 - JP 2017525350-A/100: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260842 - JP 2017505623-A/908: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673329 - Sequence 132 from Patent EP3135774.
MS833317 - Sequence 22 from Patent EP3112464.
MS833886 - Sequence 32 from Patent EP3112479.
MS901693 - Sequence 166 from Patent EP3156505.
MS904150 - Sequence 66 from Patent EP3138926.
MS944844 - Sequence 100 from Patent EP3177739.
CS330192 - Sequence 48 from Patent WO2006063356.
CS548543 - Sequence 1573 from Patent EP1777301.
DJ003845 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027124 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DL233858 - Identification of novel genes encoding for small temporal RNA.
DM119568 - Targeting Cells With Altered miRNA Expression.
FU261352 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763854 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV523087 - Identification of novel genes encoding for small temporal RNA.
FV524335 - Nucleic acid controling mast cell degranulation.
FW312439 - DETECTING NUCLEIC ACIDS.
FW362682 - MICRORNA EXPRESSION SIGNATURE FOR PREDICTING SURVIVAL AND METASTASES IN HEPATOCELLULAR CARCINOMA.
FW364627 - Oligonucleotides for modulating target RNA activity.
FZ415728 - JP 2010536372-A/8: METHODS OF USING MIRNA FOR DETECTION OF IN VIVO CELL DEATH.
HH826075 - Sequence 28 from Patent WO2010100328.
HI377389 - Sequence 16 from Patent EP2087135.
HI539281 - Sequence 105 from Patent EP2160477.
HI560806 - Sequence 21 from Patent EP2190992.
HI560808 - Sequence 23 from Patent EP2190992.
HI560809 - Sequence 24 from Patent EP2190992.
HI648420 - Sequence 1 from Patent WO2010122109.
HI964748 - Sequence 33 from Patent WO2010139812.
HI966086 - Sequence 406 from Patent WO2010139811.
HI966952 - Sequence 406 from Patent WO2010139810.
HV304753 - JP 2009531018-A/320: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305251 - JP 2009531019-A/320: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV540963 - WO 2011125469-A/7: A recombinant vaccinia virus regulated by miRNA and use thereof.
HV582962 - JP 2010527616-A/103: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS.
HV593803 - JP 2010538610-A/16: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
HV593907 - JP 2010538653-A/21: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV593909 - JP 2010538653-A/23: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV593910 - JP 2010538653-A/24: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595537 - JP 2010539959-A/918: Micromirs.
HV954015 - JP 2012518421-A/927: METHODS OF DETECTING LUNG CANCER.
HW048307 - JP 2012524758-A/1: METHOD FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA.
HW119460 - JP 2013046612-A/320: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW120868 - WO 2013038737-A/31: Bladder cancer marker.
HW505308 - JP 2014502606-A/210: MELANOMA TREATMENTS.
HW505309 - JP 2014502606-A/211: MELANOMA TREATMENTS.
HW505310 - JP 2014502606-A/212: MELANOMA TREATMENTS.
HW505335 - JP 2014502606-A/237: MELANOMA TREATMENTS.
HW505336 - JP 2014502606-A/238: MELANOMA TREATMENTS.
HW505337 - JP 2014502606-A/239: MELANOMA TREATMENTS.
HW530043 - JP 2014094008-A/104: Identification of novel genes encoding for small temporal RNA.
HW589789 - JP 2013121348-A/320: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW913432 - JP 2015504307-A/192: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ043371 - JP 2015510401-A/461: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074110 - JP 2013535982-A/201: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ081997 - JP 2015514392-A/461: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082701 - JP 2015513906-A/58: Stem Cell Microparticles.
HZ158094 - JP 2015130862-A/918: Micromirs.
HZ186940 - JP 2015146814-A/689: Oligonucleotides for modulating target RNA activity.
HZ413593 - JP 2014060993-A/320: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ432170 - JP 2014207909-A/103: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS.
HZ436482 - JP 2015529450-A/58: Stem Cell Microparticles.
HZ482646 - JP 2015535430-A/3152: TERMINALLY MODIFIED RNA.
HZ501804 - JP 2016025853-A/320: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ792577 - JP 2016504050-A/4322: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA400786 - Sequence 33 from Patent WO2011080318.
JA401764 - Sequence 33 from Patent WO2011080315.
JA402771 - Sequence 33 from Patent WO2011080316.
JA405402 - Sequence 33 from Patent EP2336353.
JA427166 - Sequence 499 from Patent WO2011072177.
JA428928 - Sequence 33 from Patent WO2011095623.
JA526170 - Sequence 320 from Patent EP2369011.
JA526677 - Sequence 320 from Patent EP2369012.
JA527184 - Sequence 320 from Patent EP2369013.
JA536113 - Sequence 320 from Patent EP2371971.
JA641984 - Sequence 104 from Patent EP2386637.
JA663269 - Sequence 104 from Patent EP2385122.
JA663486 - Sequence 104 from Patent EP2385123.
JA715145 - Sequence 927 from Patent EP2401406.
JA788118 - Sequence 320 from Patent EP2479285.
JA788616 - Sequence 320 from Patent EP2479286.
JA810950 - Sequence 320 from Patent EP2468890.
JA811448 - Sequence 320 from Patent EP2468891.
JA811946 - Sequence 320 from Patent EP2468893.
JA812444 - Sequence 320 from Patent EP2468894.
JA812942 - Sequence 320 from Patent EP2468895.
JA813440 - Sequence 320 from Patent EP2468896.
JA813938 - Sequence 320 from Patent EP2468897.
JA814436 - Sequence 320 from Patent EP2468898.
JA814934 - Sequence 320 from Patent EP2468899.
JA817177 - Sequence 320 from Patent EP2468892.
JA825989 - Sequence 320 from Patent EP2471956.
JA826487 - Sequence 320 from Patent EP2471958.
JB022665 - Sequence 507 from Patent WO2013026685.
JB024774 - Sequence 320 from Patent EP2505668.
JB025272 - Sequence 320 from Patent EP2505669.
JB073531 - Sequence 4 from Patent EP2546361.
JB079659 - Sequence 320 from Patent EP2487252.
JB080157 - Sequence 320 from Patent EP2487253.
JB080655 - Sequence 320 from Patent EP2487254.
JB081153 - Sequence 320 from Patent EP2487255.
JB081651 - Sequence 320 from Patent EP2487256.
JB082149 - Sequence 320 from Patent EP2487257.
JB082647 - Sequence 320 from Patent EP2487258.
JB083145 - Sequence 320 from Patent EP2487259.
JB083643 - Sequence 320 from Patent EP2487260.
JB084141 - Sequence 320 from Patent EP2487261.
JB084639 - Sequence 320 from Patent EP2487262.
JB085137 - Sequence 320 from Patent EP2487263.
JB087815 - Sequence 320 from Patent EP2502630.
JB148019 - Sequence 320 from Patent EP2484782.
JB148517 - Sequence 320 from Patent EP2484783.
JB153242 - Sequence 320 from Patent EP2514433.
JB153740 - Sequence 320 from Patent EP2514434.
JB175199 - Sequence 231 from Patent WO2012101219.
JB292066 - Sequence 104 from Patent EP2428569.
JB302181 - Sequence 104 from Patent EP2428570.
JB320136 - Sequence 104 from Patent EP2428568.
JB336199 - Sequence 104 from Patent EP2428571.
JB361386 - Sequence 104 from Patent EP2428567.
JB620286 - Sequence 266 from Patent WO2013063544.
JB622329 - Sequence 320 from Patent EP2586454.
JB622827 - Sequence 320 from Patent EP2586455.
JB624201 - Sequence 21 from Patent EP2610342.
JB624203 - Sequence 23 from Patent EP2610342.
JB624204 - Sequence 24 from Patent EP2610342.
JB778813 - Sequence 192 from Patent WO2013078283.
JB835737 - Sequence 27 from Patent WO2013057567.
JC001890 - Sequence 320 from Patent EP2591794.
JC023580 - Sequence 96 from Patent EP2641976.
JC032750 - Sequence 22 from Patent WO2013160474.
JC037701 - Sequence 229 from Patent EP2643479.
JC107391 - Sequence 17 from Patent WO2013175446.
JC171686 - Sequence 58 from Patent WO2013150303.
JC244394 - Sequence 14 from Patent WO2012020308.
JC334281 - Sequence 199 from Patent EP2487240.
JC515309 - Sequence 5562 from Patent WO2014113089.
JC572497 - Sequence 58 from Patent WO2014125276.
JC582185 - Sequence 58 from Patent WO2014125277.
JD568349 - Sequence 8 from Patent WO2015007294.
JD568617 - Sequence 7 from Patent WO2015007293.
JE867484 - Sequence 291 from Patent WO2015128671.
JE953881 - Sequence 58 from Patent WO2015052526.
JE955634 - Sequence 58 from Patent WO2015052527.
LF137386 - JP 2016507550-A/58: Method of Producing Microparticles.
LF161089 - JP 2016513950-A/1155: Oligomers with improved off-target profile.
LF162351 - JP 2016513095-A/58: Stem Cell Microparticles and miRNA.
LF404479 - JP 2015509366-A/472: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
LF857567 - JP 2015130879-A/16: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER.
LF953103 - JP 2016534103-A/58: Stem Cell Microparticles and miRNA.
LG005448 - KR 1020150004822-A/58: STEM CELL MICROPARTICLES.
LG053144 - KR 1020150059168-A/58: STEM CELL MICROPARTICLES.
LG240383 - KR 1020160035087-A/58: STEM CELL MICROPARTICLES AND MIRNA.
LP726712 - Sequence 406 from Patent EP2883966.
LP818982 - Sequence 406 from Patent EP3296406.
LP938924 - Sequence 406 from Patent EP3184651.
LQ072897 - Sequence 3221 from Patent EP2964234.
LQ402661 - Sequence 1 from Patent EP3036345.
LQ500602 - Sequence 16 from Patent EP3048177.
LV470468 - JP 2016534036-A/58: Stem Cell Microparticles and miRNA.
LV539164 - JP 2016539127-A/165: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LX154643 - JP 2017509333-A/291: Biomarkers for Endometriosis.
LY298566 - KR 1020160079824-A/165: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY405602 - KR 1020160117535-A/907: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY504656 - KR 1020170035932-A/45: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ234297 - JP 2017184756-A/689: Oligonucleotides for modulating target RNA activity.
LZ242937 - JP 2017525350-A/45: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260841 - JP 2017505623-A/907: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA354010 - JP 2018075017-A/472: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.
MS816869 - Sequence 218 from Patent WO2017085287.
MS833316 - Sequence 21 from Patent EP3112464.
MS833318 - Sequence 23 from Patent EP3112464.
MS833319 - Sequence 24 from Patent EP3112464.
MS833887 - Sequence 33 from Patent EP3112479.
MS887076 - Sequence 2 from Patent WO2017005646.
MS887286 - Sequence 2 from Patent WO2017006145.
MS902034 - Sequence 507 from Patent EP3156505.
MS904100 - Sequence 16 from Patent EP3138926.
MS944789 - Sequence 45 from Patent EP3177739.
AK309800 - Homo sapiens cDNA, FLJ99841.
MA013405 - WO 2018003988-A/25: Nucleic Acids and Composition for Treating Tumors Including Brain Tumor.
MA013407 - WO 2018003988-A/27: Nucleic Acids and Composition for Treating Tumors Including Brain Tumor.
MA646391 - JP 2017113010-A/4315: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA734275 - JP 2017140048-A/3145: TERMINALLY MODIFIED RNA.
MA646398 - JP 2017113010-A/4322: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA734282 - JP 2017140048-A/3152: TERMINALLY MODIFIED RNA.
LQ955735 - Sequence 66 from Patent EP2775001.
LQ955685 - Sequence 16 from Patent EP2775001.
MA406429 - JP 2018518147-A/59: Detection of Brain Injury.
MA406394 - JP 2018518147-A/24: Detection of Brain Injury.
MA421913 - JP 2018520150-A/2: METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS.
MP045650 - Sequence 472 from Patent EP3401394.
MP084309 - Sequence 461 from Patent EP3401393.
MA803444 - JP 2018183181-A/4315: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA803451 - JP 2018183181-A/4322: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MP129283 - Sequence 183 from Patent EP3470073.
MP162206 - Sequence 183 from Patent WO2019069093.
MA854168 - WO 2019031595-A/731: Method for sorting neural progenitor cell.
MP129158 - Sequence 58 from Patent EP3470073.
MP162081 - Sequence 58 from Patent WO2019069093.
MP264417 - Sequence 4 from Patent EP3502269.
MP280774 - Sequence 194 from Patent WO2019111197.
MP283687 - Sequence 194 from Patent WO2019111198.
MP280775 - Sequence 195 from Patent WO2019111197.
MP283688 - Sequence 195 from Patent WO2019111198.

-  Other Names for This Gene
  Alternate Gene Symbols: AX746931
UCSC ID: uc003kjg.3
RefSeq Accession: NR_024384

-  Gene Model Information
 
category: noncoding nonsense-mediated-decay: no RNA accession: AX746931.1
exon count: 4CDS single in 3' UTR: no RNA size: 2300
ORF size: 0CDS single in intron: no Alignment % ID: 99.83
txCdsPredict score: 87.00frame shift in genome: no % Coverage: 99.96
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.